Phase 3 CKD Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
CKDMetabolic Acidosis
Renibus Therapeutics, Inc.150 enrolled16 locationsNCT07355062
Recruiting
Phase 3
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
Chronic Kidney Disease(CKD)Uncontrolled Hypertension
University Hospital, Tours720 enrolled40 locationsNCT05732727
Recruiting
Phase 3
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease
Chronic Kidney Disease Stage 5CKD Stage 4
Ain Shams University60 enrolled1 locationNCT06982079
Recruiting
Phase 2Phase 3
Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study
BiomarkersAKI - Acute Kidney InjuryCKD+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran100 enrolled1 locationNCT05713851